HEADER HYDROLASE INHIBITOR 22-SEP-18 6HPV TITLE CRYSTAL STRUCTURE OF MOUSE FETUIN-B COMPND MOL_ID: 1; COMPND 2 MOLECULE: FETUIN-B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FETUIN-LIKE PROTEIN IRL685; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: FETUB; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI-; SOURCE 9 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PHLSEC2 KEYWDS GLYCOPROTEIN, CYSTATIN DOMAIN, FERTILIZATION, EGG COAT, ZONA KEYWDS 2 PELLUCIDA, HARDENING, METALLOPROTEASE INHIBITOR, OVASTACIN, ZP2, KEYWDS 3 HYDROLASE INHIBITOR, LIVER-SECRETED PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.FAHRENKAMP,E.DIETZEL,D.DE SANCTIS,L.JOVINE REVDAT 3 29-JUL-20 6HPV 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 27-MAR-19 6HPV 1 JRNL REVDAT 1 20-FEB-19 6HPV 0 JRNL AUTH A.CUPPARI,H.KORSCHGEN,D.FAHRENKAMP,C.SCHMITZ,T.GUEVARA, JRNL AUTH 2 K.KARMILIN,M.KUSKE,M.OLF,E.DIETZEL,I.YIALLOUROS, JRNL AUTH 3 D.DE SANCTIS,T.GOULAS,R.WEISKIRCHEN,W.JAHNEN-DECHENT, JRNL AUTH 4 J.FLOEHR,W.STOECKER,L.JOVINE,F.X.GOMIS-RUTH JRNL TITL STRUCTURE OF MAMMALIAN PLASMA FETUIN-B AND ITS MECHANISM OF JRNL TITL 2 SELECTIVE METALLOPEPTIDASE INHIBITION. JRNL REF IUCRJ V. 6 317 2019 JRNL REFN ESSN 2052-2525 JRNL PMID 30867929 JRNL DOI 10.1107/S2052252519001568 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.OLIVIER,E.SOURY,P.RUMINY,A.HUSSON,F.PARMENTIER,M.DAVEAU, REMARK 1 AUTH 2 J.P.SALIER REMARK 1 TITL FETUIN-B, A SECOND MEMBER OF THE FETUIN FAMILY IN MAMMALS. REMARK 1 REF BIOCHEM. J. V.PT 2 589 2000 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 10947975 REMARK 1 DOI 10.1042/BJ3500589 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.DENECKE,S.GRABER,C.SCHAFER,A.HEISS,M.WOLTJE, REMARK 1 AUTH 2 W.JAHNEN-DECHENT REMARK 1 TITL TISSUE DISTRIBUTION AND ACTIVITY TESTING SUGGEST A SIMILAR REMARK 1 TITL 2 BUT NOT IDENTICAL FUNCTION OF FETUIN-B AND FETUIN-A. REMARK 1 REF BIOCHEM. J. V. 376 135 2003 REMARK 1 REFN ESSN 1470-8728 REMARK 1 PMID 12943536 REMARK 1 DOI 10.1042/BJ20030676 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.DIETZEL,J.WESSLING,J.FLOEHR,C.SCHAFER,S.ENSSLEN,B.DENECKE, REMARK 1 AUTH 2 B.ROSING,J.NEULEN,T.VEITINGER,M.SPEHR,T.TROPARTZ,R.TOLBA, REMARK 1 AUTH 3 T.RENNE,A.EGERT,H.SCHORLE,Y.GOTTENBUSCH,A.HILDEBRAND, REMARK 1 AUTH 4 I.YIALLOUROS,W.STOCKER,R.WEISKIRCHEN,W.JAHNEN-DECHENT REMARK 1 TITL FETUIN-B, A LIVER-DERIVED PLASMA PROTEIN IS ESSENTIAL FOR REMARK 1 TITL 2 FERTILIZATION. REMARK 1 REF DEV. CELL V. 25 106 2013 REMARK 1 REFN ISSN 1878-1551 REMARK 1 PMID 23562279 REMARK 1 DOI 10.1016/J.DEVCEL.2013.03.001 REMARK 1 REFERENCE 4 REMARK 1 AUTH W.STOCKER,K.KARMILIN,A.HILDEBRAND,H.WESTPHAL,I.YIALLOUROS, REMARK 1 AUTH 2 R.WEISKIRCHEN,E.DIETZEL,J.FLOEHR,W.JAHNEN-DECHENT REMARK 1 TITL MAMMALIAN GAMETE FUSION DEPENDS ON THE INHIBITION OF REMARK 1 TITL 2 OVASTACIN BY FETUIN-B. REMARK 1 REF BIOL. CHEM. V. 395 1195 2014 REMARK 1 REFN ISSN 1437-4315 REMARK 1 PMID 25205729 REMARK 1 DOI 10.1515/HSZ-2014-0189 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.C.MEEX,A.J.HOY,A.MORRIS,R.D.BROWN,J.C.LO,M.BURKE, REMARK 1 AUTH 2 R.J.GOODE,B.A.KINGWELL,M.J.KRAAKMAN,M.A.FEBBRAIO,J.W.GREVE, REMARK 1 AUTH 3 S.S.RENSEN,M.P.MOLLOY,G.I.LANCASTER,C.R.BRUCE,M.J.WATT REMARK 1 TITL FETUIN B IS A SECRETED HEPATOCYTE FACTOR LINKING STEATOSIS REMARK 1 TITL 2 TO IMPAIRED GLUCOSE METABOLISM. REMARK 1 REF CELL METAB. V. 22 1078 2015 REMARK 1 REFN ESSN 1932-7420 REMARK 1 PMID 26603189 REMARK 1 DOI 10.1016/J.CMET.2015.09.023 REMARK 1 REFERENCE 6 REMARK 1 AUTH J.FLOEHR,E.DIETZEL,J.NEULEN,B.ROSING,U.WEISSENBORN, REMARK 1 AUTH 2 W.JAHNEN-DECHENT REMARK 1 TITL ASSOCIATION OF HIGH FETUIN-B CONCENTRATIONS IN SERUM WITH REMARK 1 TITL 2 FERTILIZATION RATE IN IVF: A CROSS-SECTIONAL PILOT STUDY. REMARK 1 REF HUM. REPROD. V. 31 630 2016 REMARK 1 REFN ISSN 1460-2350 REMARK 1 PMID 26759143 REMARK 1 DOI 10.1093/HUMREP/DEV340 REMARK 1 REFERENCE 7 REMARK 1 AUTH E.DIETZEL,J.FLOEHR,E.VAN DE LEUR,R.WEISKIRCHEN, REMARK 1 AUTH 2 W.JAHNEN-DECHENT REMARK 1 TITL RECOMBINANT FETUIN-B PROTEIN MAINTAINS HIGH FERTILIZATION REMARK 1 TITL 2 RATE IN CUMULUS CELL-FREE MOUSE OOCYTES. REMARK 1 REF MOL. HUM. REPROD. V. 23 25 2017 REMARK 1 REFN ISSN 1460-2407 REMARK 1 PMID 27733489 REMARK 1 DOI 10.1093/MOLEHR/GAW067 REMARK 1 REFERENCE 8 REMARK 1 AUTH S.KRALISCH,A.HOFFMANN,N.KLOTING,A.BACHMANN,J.KRATZSCH, REMARK 1 AUTH 2 M.BLUHER,M.Z.ZHANG,R.C.HARRIS,M.STUMVOLL,M.FASSHAUER,T.EBERT REMARK 1 TITL THE NOVEL ADIPOKINE/HEPATOKINE FETUIN B IN SEVERE HUMAN AND REMARK 1 TITL 2 MURINE DIABETIC KIDNEY DISEASE. REMARK 1 REF DIABETES METAB. V. 43 465 2017 REMARK 1 REFN ISSN 1878-1780 REMARK 1 PMID 28214129 REMARK 1 DOI 10.1016/J.DIABET.2017.01.005 REMARK 1 REFERENCE 9 REMARK 1 AUTH M.M.RABADI,W.ABDULMAHDI,L.NESI,E.JULES,Y.MARGHANI,E.SHEININ, REMARK 1 AUTH 2 J.TILZER,S.GUPTA,S.CHEN,N.D.CASSIMATIS,M.LIPPHARDT, REMARK 1 AUTH 3 P.B.KOZLOWSKI,B.B.RATLIFF REMARK 1 TITL MATERNAL MALNOURISHMENT INDUCED UPREGULATION OF FETUIN-B REMARK 1 TITL 2 BLUNTS NEPHROGENESIS IN THE LOW BIRTH WEIGHT NEONATE. REMARK 1 REF DEV. BIOL. V. 443 78 2018 REMARK 1 REFN ESSN 1095-564X REMARK 1 PMID 30189195 REMARK 1 DOI 10.1016/J.YDBIO.2018.09.001 REMARK 1 REFERENCE 10 REMARK 1 AUTH K.KARMILIN,C.SCHMITZ,M.KUSKE,H.KORSCHGEN,M.OLF,K.MEYER, REMARK 1 AUTH 2 A.HILDEBRAND,M.FELTEN,S.FRIDRICH,I.YIALLOUROS, REMARK 1 AUTH 3 C.BECKER-PAULY,R.WEISKIRCHEN,W.JAHNEN-DECHENT,J.FLOEHR, REMARK 1 AUTH 4 W.STOCKER REMARK 1 TITL MAMMALIAN PLASMA FETUIN-B IS A SELECTIVE INHIBITOR OF REMARK 1 TITL 2 OVASTACIN AND MEPRIN METALLOPROTEINASES. REMARK 1 REF SCI REP V. 9 546 2019 REMARK 1 REFN ESSN 2045-2322 REMARK 1 PMID 30679641 REMARK 1 DOI 10.1038/S41598-018-37024-5 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14-3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 19991 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.8886 - 4.3986 1.00 3122 165 0.1933 0.2023 REMARK 3 2 4.3986 - 3.4917 1.00 2926 154 0.1935 0.2342 REMARK 3 3 3.4917 - 3.0504 1.00 2882 152 0.2482 0.2907 REMARK 3 4 3.0504 - 2.7715 1.00 2872 151 0.2740 0.3045 REMARK 3 5 2.7715 - 2.5729 0.99 2799 147 0.3014 0.3712 REMARK 3 6 2.5729 - 2.4212 0.89 2489 130 0.3050 0.3457 REMARK 3 7 2.4212 - 2.2999 0.67 1901 101 0.3132 0.3560 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2435 REMARK 3 ANGLE : 0.586 3316 REMARK 3 CHIRALITY : 0.043 372 REMARK 3 PLANARITY : 0.006 434 REMARK 3 DIHEDRAL : 13.365 942 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND RESI 31:157 OR RESI 296:388 OR RESI REMARK 3 900:910 REMARK 3 ORIGIN FOR THE GROUP (A): 5.9280 23.1794 85.1170 REMARK 3 T TENSOR REMARK 3 T11: 0.4378 T22: 0.4329 REMARK 3 T33: 0.4657 T12: 0.0663 REMARK 3 T13: 0.0100 T23: -0.0040 REMARK 3 L TENSOR REMARK 3 L11: 1.7016 L22: 0.1763 REMARK 3 L33: 2.0508 L12: 0.5417 REMARK 3 L13: -0.5046 L23: -0.0911 REMARK 3 S TENSOR REMARK 3 S11: -0.0130 S12: -0.0717 S13: 0.0549 REMARK 3 S21: 0.0624 S22: 0.0498 S23: 0.0242 REMARK 3 S31: -0.1597 S32: -0.0953 S33: -0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND RESI 158:269 REMARK 3 ORIGIN FOR THE GROUP (A): 18.2715 38.6262 61.4045 REMARK 3 T TENSOR REMARK 3 T11: 0.5014 T22: 0.5610 REMARK 3 T33: 0.5847 T12: 0.0183 REMARK 3 T13: 0.0258 T23: 0.1770 REMARK 3 L TENSOR REMARK 3 L11: 0.8807 L22: 0.6143 REMARK 3 L33: 0.8206 L12: -0.6638 REMARK 3 L13: -0.5987 L23: 0.2330 REMARK 3 S TENSOR REMARK 3 S11: 0.0693 S12: 0.4338 S13: 0.3802 REMARK 3 S21: -0.1846 S22: 0.0361 S23: -0.2094 REMARK 3 S31: 0.0003 S32: -0.1510 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HPV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1200012050. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.7712 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 26, 2018 BUILT=20180409 REMARK 200 DATA SCALING SOFTWARE : XSCALE JAN 26, 2018 REMARK 200 BUILT=20180409 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19993 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 200 DATA REDUNDANCY : 19.30 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 63.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 1.62600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.360 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: CRANK2 2.0.166 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 150 MM NACL, 100 MM NAOAC, 20 MM NA REMARK 280 -HEPES PH 7.8, 25% PEG 4000, 8% ISOPROPANOL, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 98.90500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 33.85500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 33.85500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 49.45250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 33.85500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 33.85500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 148.35750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 33.85500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 33.85500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 49.45250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 33.85500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 33.85500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 148.35750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 98.90500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 573 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 19 REMARK 465 SER A 20 REMARK 465 PRO A 21 REMARK 465 PRO A 22 REMARK 465 ALA A 23 REMARK 465 PRO A 24 REMARK 465 PRO A 25 REMARK 465 LEU A 26 REMARK 465 PRO A 27 REMARK 465 GLN A 28 REMARK 465 ARG A 29 REMARK 465 PRO A 30 REMARK 465 THR A 218 REMARK 465 LYS A 219 REMARK 465 SER A 220 REMARK 465 GLN A 221 REMARK 465 ALA A 222 REMARK 465 SER A 223 REMARK 465 CYS A 224 REMARK 465 SER A 225 REMARK 465 LEU A 226 REMARK 465 GLN A 227 REMARK 465 HIS A 228 REMARK 465 SER A 244 REMARK 465 SER A 245 REMARK 465 LEU A 246 REMARK 465 ARG A 247 REMARK 465 HIS A 248 REMARK 465 VAL A 249 REMARK 465 PRO A 250 REMARK 465 LEU A 251 REMARK 465 ILE A 252 REMARK 465 GLN A 253 REMARK 465 PRO A 254 REMARK 465 VAL A 255 REMARK 465 ALA A 270 REMARK 465 GLN A 271 REMARK 465 VAL A 272 REMARK 465 PRO A 273 REMARK 465 GLY A 274 REMARK 465 ASP A 275 REMARK 465 GLU A 276 REMARK 465 ASN A 277 REMARK 465 PRO A 278 REMARK 465 ALA A 279 REMARK 465 VAL A 280 REMARK 465 THR A 281 REMARK 465 GLN A 282 REMARK 465 GLY A 283 REMARK 465 PRO A 284 REMARK 465 GLN A 285 REMARK 465 LYS A 286 REMARK 465 LEU A 287 REMARK 465 PRO A 288 REMARK 465 GLN A 289 REMARK 465 LYS A 290 REMARK 465 ASN A 291 REMARK 465 THR A 292 REMARK 465 ALA A 293 REMARK 465 PRO A 294 REMARK 465 THR A 295 REMARK 465 GLU A 316 REMARK 465 LYS A 317 REMARK 465 PRO A 318 REMARK 465 GLU A 319 REMARK 465 GLU A 320 REMARK 465 SER A 321 REMARK 465 LYS A 322 REMARK 465 GLY A 323 REMARK 465 GLY A 324 REMARK 465 SER A 325 REMARK 465 LEU A 389 REMARK 465 GLU A 390 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 HIS A 393 REMARK 465 HIS A 394 REMARK 465 HIS A 395 REMARK 465 HIS A 396 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 79 -21.55 72.32 REMARK 500 ASP A 80 -25.46 -141.97 REMARK 500 ASN A 139 138.41 -170.42 REMARK 500 CYS A 154 81.49 -152.94 REMARK 500 PRO A 298 67.18 -67.88 REMARK 500 VAL A 300 -62.67 -105.29 REMARK 500 PRO A 303 -168.24 -72.74 REMARK 500 ARG A 304 132.07 -37.61 REMARK 500 REMARK 500 REMARK: NULL DBREF 6HPV A 19 388 UNP Q9QXC1 FETUB_MOUSE 19 388 SEQADV 6HPV LEU A 389 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV GLU A 390 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV HIS A 391 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV HIS A 392 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV HIS A 393 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV HIS A 394 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV HIS A 395 UNP Q9QXC1 EXPRESSION TAG SEQADV 6HPV HIS A 396 UNP Q9QXC1 EXPRESSION TAG SEQRES 1 A 378 ARG SER PRO PRO ALA PRO PRO LEU PRO GLN ARG PRO LEU SEQRES 2 A 378 SER PRO LEU HIS PRO LEU GLY CYS ASN ASP SER GLU VAL SEQRES 3 A 378 LEU ALA VAL ALA GLY PHE ALA LEU GLN ASN ILE ASN ARG SEQRES 4 A 378 ASP GLN LYS ASP GLY TYR MET LEU SER LEU ASN ARG VAL SEQRES 5 A 378 HIS ASP VAL ARG GLU HIS TYR GLN GLU ASP MET GLY SER SEQRES 6 A 378 LEU PHE TYR LEU THR LEU ASP VAL LEU GLU THR ASP CYS SEQRES 7 A 378 HIS VAL LEU SER ARG LYS ALA GLN LYS ASP CYS LYS PRO SEQRES 8 A 378 ARG MET PHE TYR GLU SER VAL TYR GLY GLN CYS LYS ALA SEQRES 9 A 378 MET PHE HIS ILE ASN LYS PRO ARG ARG VAL LEU TYR LEU SEQRES 10 A 378 PRO ALA TYR ASN CYS THR LEU ARG PRO VAL SER LYS ARG SEQRES 11 A 378 LYS THR HIS THR THR CYS PRO ASP CYS PRO SER PRO ILE SEQRES 12 A 378 ASP LEU SER ASN PRO SER ALA LEU GLU ALA ALA THR GLU SEQRES 13 A 378 SER LEU ALA LYS PHE ASN SER LYS SER PRO SER LYS LYS SEQRES 14 A 378 TYR GLU LEU VAL LYS VAL THR LYS ALA MET ASN GLN TRP SEQRES 15 A 378 VAL SER GLY PRO ALA TYR TYR VAL GLU TYR LEU ILE LYS SEQRES 16 A 378 GLU ALA PRO CYS THR LYS SER GLN ALA SER CYS SER LEU SEQRES 17 A 378 GLN HIS SER ASP SER GLU PRO VAL GLY ILE CYS GLN GLY SEQRES 18 A 378 SER THR VAL GLN SER SER LEU ARG HIS VAL PRO LEU ILE SEQRES 19 A 378 GLN PRO VAL GLU LYS SER VAL THR VAL THR CYS GLU PHE SEQRES 20 A 378 PHE GLU SER GLN ALA GLN VAL PRO GLY ASP GLU ASN PRO SEQRES 21 A 378 ALA VAL THR GLN GLY PRO GLN LYS LEU PRO GLN LYS ASN SEQRES 22 A 378 THR ALA PRO THR SER SER PRO SER VAL THR ALA PRO ARG SEQRES 23 A 378 GLY SER ILE GLN HIS LEU PRO GLU LEU ASP ASP GLU LYS SEQRES 24 A 378 PRO GLU GLU SER LYS GLY GLY SER PRO GLU GLU ALA PHE SEQRES 25 A 378 PRO VAL GLN LEU ASP LEU THR THR ASN PRO GLN GLY ASP SEQRES 26 A 378 THR LEU ASP VAL SER PHE LEU TYR LEU GLU PRO GLY ASP SEQRES 27 A 378 LYS LYS LEU VAL VAL LEU PRO PHE PRO GLY LYS GLU GLN SEQRES 28 A 378 ARG SER ALA GLU CYS PRO GLY PRO GLU LYS GLU ASN ASN SEQRES 29 A 378 PRO LEU VAL LEU PRO PRO LEU GLU HIS HIS HIS HIS HIS SEQRES 30 A 378 HIS HET NAG A 401 28 HET NAG A 402 28 HET ACT A 403 7 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ACT ACETATE ION FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 ACT C2 H3 O2 1- FORMUL 5 HOH *85(H2 O) HELIX 1 AA1 ASP A 41 GLN A 59 1 19 HELIX 2 AA2 LEU A 99 ARG A 101 5 3 HELIX 3 AA3 ALA A 103 CYS A 107 5 5 HELIX 4 AA4 MET A 111 GLU A 114 5 4 HELIX 5 AA5 SER A 146 CYS A 154 1 9 HELIX 6 AA6 ASN A 165 LYS A 182 1 18 HELIX 7 AA7 SER A 348 TYR A 351 5 4 SHEET 1 AA1 6 HIS A 35 PRO A 36 0 SHEET 2 AA1 6 TYR A 63 TYR A 77 -1 O GLU A 75 N HIS A 35 SHEET 3 AA1 6 SER A 83 HIS A 97 -1 O TYR A 86 N ARG A 74 SHEET 4 AA1 6 VAL A 116 ASN A 127 -1 O PHE A 124 N PHE A 85 SHEET 5 AA1 6 VAL A 132 PRO A 144 -1 O TYR A 134 N HIS A 125 SHEET 6 AA1 6 GLY A 305 HIS A 309 1 O GLN A 308 N LEU A 142 SHEET 1 AA2 5 SER A 159 PRO A 160 0 SHEET 2 AA2 5 TYR A 188 TRP A 200 -1 O ASN A 198 N SER A 159 SHEET 3 AA2 5 PRO A 204 GLU A 214 -1 O LYS A 213 N GLU A 189 SHEET 4 AA2 5 PRO A 233 VAL A 242 -1 O VAL A 234 N ILE A 212 SHEET 5 AA2 5 SER A 258 PHE A 265 -1 O THR A 262 N GLN A 238 SHEET 1 AA3 2 ASP A 343 ASP A 346 0 SHEET 2 AA3 2 LYS A 358 VAL A 361 -1 O LEU A 359 N LEU A 345 SSBOND 1 CYS A 39 CYS A 374 1555 1555 2.04 SSBOND 2 CYS A 96 CYS A 107 1555 1555 2.03 SSBOND 3 CYS A 120 CYS A 140 1555 1555 2.03 SSBOND 4 CYS A 154 CYS A 157 1555 1555 2.03 SSBOND 5 CYS A 237 CYS A 263 1555 1555 2.03 LINK ND2 ASN A 40 C1 NAG A 401 1555 1555 1.43 LINK ND2 ASN A 139 C1 NAG A 402 1555 1555 1.42 CISPEP 1 CYS A 374 PRO A 375 0 1.24 CRYST1 67.710 67.710 197.810 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014769 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014769 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005055 0.00000